<?xml version='1.0' encoding='UTF-8'?>
<rss version='2.0' xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Publications for Francesca  Gilli, MS, PhD</title>
    <link>https://geiselmed.dartmouth.edu/faculty/facultydb/view.php?uid=6199</link>
    <description>Publications for Francesca  Gilli, MS, PhD</description>
    <language>en-us</language>

    <item>
      <title><![CDATA[Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosis.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/41786004</link>
      <description><![CDATA[Linzey M, Pike SC, Bouzid NM, Scholand A, Cruz CG, Philips A, DeCristofano L, Tran H, Gilli F <br />Brain Behav Immun. 2026 Mar 3;135:106526. doi: 10.1016/j.bbi.2026.106526. Epub 2026 Mar 3. <br /> PMID: 41786004]]></description>
    </item>
    <item>
      <title><![CDATA[Network analysis of intrathecally synthesized proteins to unravel mechanisms of disease course in multiple sclerosis.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/40614326</link>
      <description><![CDATA[Welsh NC, DiSano KD, Pike SC, Linzey M, Smith AD 3rd, Pachner AR, Gilli F <br />J Neuroimmunol. 2025 Sep 15;406:578678. doi: 10.1016/j.jneuroim.2025.578678. Epub 2025 Jun 29. <br /> PMID: 40614326]]></description>
    </item>
    <item>
      <title><![CDATA[The CXCL13 index biomarker predicts success or failure of moderate-efficacy disease-modifying therapies in multiple sclerosis; A real-world study.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/39914154</link>
      <description><![CDATA[Pachner AR, Pike SC, Smith AD, Gilli F <br />Mult Scler Relat Disord. 2025 Mar;95:106303. doi: 10.1016/j.msard.2025.106303. Epub 2025 Jan 29. <br /> PMID: 39914154]]></description>
    </item>
    <item>
      <title><![CDATA[CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/39766248</link>
      <description><![CDATA[Pachner AR, Pike S, Smith AD, Gilli F <br />Biomolecules. 2024 Nov 30;14(12) doi: 10.3390/biom14121541. Epub 2024 Nov 30. <br /> PMID: 39766248]]></description>
    </item>
    <item>
      <title><![CDATA[Effects of a similar amount of regular non-structured or competitive physical activity across late adulthood: a cross-sectional study.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/38873229</link>
      <description><![CDATA[Palumbo M, Modena R, Bortolan L, Skafidas S, Callovini A, Savoldelli A, Gilli F, Fornasiero A, Schena F, Pellegrini B, Zoppirolli C <br />Front Sports Act Living. 2024;6:1416080. doi: 10.3389/fspor.2024.1416080. Epub 2024 May 30. <br /> PMID: 38873229]]></description>
    </item>
    <item>
      <title><![CDATA[CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease Activity.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/38346270</link>
      <description><![CDATA[Welsh N, Disano K, Linzey M, Pike SC, Smith AD 3rd, Pachner AR, Gilli F <br />Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200200. doi: 10.1212/NXI.0000000000200200. Epub 2024 Feb 12. <br /> PMID: 38346270]]></description>
    </item>
    <item>
      <title><![CDATA[Immunological shifts during early-stage Parkinson's disease identified with DNA methylation data on longitudinally collected blood samples.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/38212355</link>
      <description><![CDATA[Pike SC, Havrda M, Gilli F, Zhang Z, Salas LA <br />NPJ Parkinsons Dis. 2024 Jan 11;10(1):21. doi: 10.1038/s41531-023-00626-6. Epub 2024 Jan 11. <br /> PMID: 38212355]]></description>
    </item>
    <item>
      <title><![CDATA[High throughput method for detecting murine brain atrophy using a clinical 3T MRI.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/37957588</link>
      <description><![CDATA[Linzey M, DiSano K, Welsh N, Ford JC, Gilli F, Wishart H, Pachner A <br />BMC Med Imaging. 2023 Nov 13;23(1):183. doi: 10.1186/s12880-023-01124-0. Epub 2023 Nov 13. <br /> PMID: 37957588]]></description>
    </item>
    <item>
      <title><![CDATA[Clinical outcomes of aspergillosis among paediatric and adult inpatients: A multicentre study in a Brazilian metropolitan area.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/37708696</link>
      <description><![CDATA[Martins AC, Psaltikidis EM, Cristiano de Lima T, Fagnani R, Gomide HCAC, Gilli FH, Schreiber AZ, de Oliveira Conterno L, Matsuzawa T, Watanabe A, Kamei K, Brandalise SR, Trabasso P, Resende MR, Moretti ML <br />J Mycol Med. 2023 Nov;33(4):101435. doi: 10.1016/j.mycmed.2023.101435. Epub 2023 Sep 5. <br /> PMID: 37708696]]></description>
    </item>
    <item>
      <title><![CDATA[The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome.]]></title>
      <link>https://www.ncbi.nlm.nih.gov/pubmed/37446228</link>
      <description><![CDATA[Pike SC, Gilli F, Pachner AR <br />Int J Mol Sci. 2023 Jul 4;24(13) doi: 10.3390/ijms241311050. Epub 2023 Jul 4. <br /> PMID: 37446228]]></description>
    </item>
  </channel>
</rss>